EUVIMEDEUVIMED entdecken
Crossref

Synthesis and Bioactivity of Novel 1,2,4‐Oxadiazole–Sulfonamide Hybrids as Potent Antibacterial Agents Against Klebsiella pneumoniae

Zohaib Saifi, Asghar Ali, Haider Thaer Abdulhameed Almuqdadi, Amir Azam, Mohammad Abid iD, Imran Ali

Chemistry & Biodiversity · 2026-03 · 23 (3)

DOI: 10.1002/cbdv.202503582 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Chemistry & Biodiversity, online erschienen am 12.03.2026. Verfasst von Zohaib Saifi und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemistry, Jamia Millia Islamia, New Delhi, India. Hauptthemen laut MEDLINE: Sulfonamides, Anti-Bacterial Agents. Die Arbeit nennt 44 Literaturangaben. Gefördert von: Core Research Grant.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

To combat resistant bacterial strains, a series of compounds (8a–8n) were synthesized in moderate to excellent yields (32.8–94.0%). These analogs were subjected to preliminary screening against various bacterial strains, including Enterococcus faecalis , Escherichia coli, Bacillus subtills, Staphylococcus aureus, Pseudomonas aeruginosa , and Klebsiella pneumoniae , to evaluate their effectiveness as antibacterial agents. Compounds 8f and 8i were the most effective derivatives, displaying their best antibacterial activity against K. pneumoniae with MIC values of 16 and 32 µg/mL, respectively. Additionally, compound 8f demonstrated a beneficial synergistic effect with ampicillin. The compound 8f was found to show good interactions with dihydropteroate synthase via hydrogen bonding, π‐cation interaction and π‐π stacking interactions. The binding free energy (BFE) value was calculated to be −63.91 Kcal/mol. The molecular dynamics simulation showed low RMSD values (0.6 to 2.2 Å) of DHPS‐ 8f complex and apoprotein, suggesting a stronger binding affinity. Importantly, it exhibited no toxicity toward human red blood cells (hRBC). Furthermore, the absorption, distribution, metabolism, and excretion (ADME) profile of 8f indicated its favorable drug‐like characteristics.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

SulfonamidesAnti-Bacterial AgentsKlebsiella pneumoniaeMolecular Dynamics SimulationStructure-Activity RelationshipOxadiazoles

Stichwörter der Autor:innen

1,2,4‐oxadiazole‐sulfonamideDHPSMDRantibacterial agentshybridsimulation

Substanzen

1,2,4-oxadiazoleSulfonamidesAnti-Bacterial AgentsOxadiazoles

Autor:innen und Institutionen

  • Department of Chemistry, Jamia Millia Islamia, New Delhi, India.
  • Department of Biosciences, Jamia Millia Islamia, New Delhi, India.
  • Department of Biochemistry, School of Chemical and Life Sciences, Jamia Hamdard, New Delhi, India.
  • Department of Chemistry, College of Science, Al-Nahrain University, Baghdad, Iraq.

ORCID-Profile: Mohammad Abid

Förderung

  • Core Research Grant

Zitieren

APA

Saifi, Z., Ali, A., Almuqdadi, H. T. A., Azam, A., Abid, M., & Ali, I. (2026). Synthesis and Bioactivity of Novel 1,2,4‐Oxadiazole–Sulfonamide Hybrids as Potent Antibacterial Agents Against Klebsiella pneumoniae. Chemistry & Biodiversity, 23(3). https://doi.org/10.1002/cbdv.202503582

Vancouver

Saifi Z, Ali A, Almuqdadi HTA, Azam A, Abid M, Ali I. Synthesis and Bioactivity of Novel 1,2,4‐Oxadiazole–Sulfonamide Hybrids as Potent Antibacterial Agents Against Klebsiella pneumoniae. Chemistry & Biodiversity. 2026;23(3). doi:10.1002/cbdv.202503582

BibTeX
@article{Saifi2026,
  author = {Saifi, Zohaib and Ali, Asghar and Almuqdadi, Haider Thaer Abdulhameed and Azam, Amir and Abid, Mohammad and Ali, Imran},
  title = {Synthesis and Bioactivity of Novel 1,2,4‐Oxadiazole–Sulfonamide Hybrids as Potent Antibacterial Agents Against Klebsiella pneumoniae},
  journal = {Chemistry & Biodiversity},
  year = {2026},
  volume = {23},
  number = {3},
  doi = {10.1002/cbdv.202503582}
}
Kostenlos starten →